700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ ReadersThis Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
Review Article Open Access
As per the United States Food and Drug Administration, orphan drugs are defined as drugs used in diseases or circumstances which occur so infrequently in USA, that there is no reasonable expectation that the cost of developing and making available, a drug for such disease or condition will be recovered from its sales in USA. In this article, the current state of orphan drugs in different countries and the benefits provided by the drug authorities/government of the country for the development of drugs for rare disease is discussed.
To read the full article Peer-reviewed Article PDF
Author(s): Meera Sumanth S Parasher